Literature DB >> 27922252

Update on new stents and protection devices for carotid artery stenting: what we know, what we learnt recently and what we need to know.

Dimitrios N Nikas1, Xenofon Makos2, Tomoyuki Umemoto3, George Liappas4, Andrea Pacchioni5, Narek Zakarian6, Bernhard Reimers4.   

Abstract

Carotid artery stenting (CAS) is considered an alternative option to carotid endarterectomy (CEA) for significant carotid stenosis, in both symptomatic and asymptomatic patients. Comparing to CEA, CAS offers significant advantages. The most important arise from the minimally invasive nature of the procedure, which reduces the surgical complications and adds significant comfort to the patient, without compromising the efficacy. Nowadays, CAS can achieve acute and long-term outcome results comparable to CEA, maintaining low rates of periprocedural embolic events. Evolution of the stent design and routine application of protection devices, played an important role to CAS performance. In this review, we aim to present all available new data on stent design and protection devices while we pose a set of unanswered questions that need to be addressed in the future.

Entities:  

Mesh:

Year:  2016        PMID: 27922252     DOI: 10.23736/S0021-9509.16.09810-4

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  2 in total

1.  Dislocation of a cerebral protection device component during carotid stenting: A case report of favorable outcome from conservative management after failure of retrieval.

Authors:  Ilaria Tocco-Tussardi; Caterina Kulyk; Vincenzo Vindigni; Giampiero Avruscio
Journal:  Int J Surg Case Rep       Date:  2017-12-28

2.  (In)comparability of Carotid Artery Stent Characteristics: A Systematic Review on Assessment and Comparison with Manufacturer Data.

Authors:  Evelien E de Vries; Mert Kök; Astrid M Hoving; Cornelis H Slump; Raechel J Toorop; Gert J de Borst
Journal:  Cardiovasc Intervent Radiol       Date:  2020-05-14       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.